Research articlePublished 3 May 2019
Stability indicating method development and validation for the estimation of atazanavir sulfate in pharmaceutical dosage forms by RP-HPLC
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A simple, precise, accurate, stability indicating method was developed for the estimation of Atazanavir sulfate in bulk drug and pharmaceutical dosage form by RP-HPLC. The separation was done using inertsil C-18 (250mm × 4.6mm, 5μ) column at a flow rate of 1mL/min with a column temperature of 30ºC on an isocratic mode. The detection wavelength used is 248nm. The mobile phase used is potassium dihydrogen phosphate (0.01N) and acetonitrile in the ratio of 55:45 (v/v). The performance of the method was validated according to the ICH guidelines for specificity, linearity, accuracy, precision, ruggedness and robustness. The retention time for Atazanavir sulfate was found to be 2.56mins. A good linear response was observed in the concentration range of 25μg/mL to 150μg/mL, with a correlation coefficient of 0.999. Atazanavir sulfate was subjected to stress conditions including acidic, alkaline, oxidation, neutral degradation, thermal degradation and photolysis, and the net degradation was found to be within the limits.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jahnavi Bandla”
- BylineArticles whose byline prints “S. Ganapaty”
- BylineArticles whose byline prints “Gorja Ashok”